Carillon Tower Advisers Inc. Has $103.65 Million Stock Position in Synopsys, Inc. (NASDAQ:SNPS)

Share on StockTwits

Carillon Tower Advisers Inc. boosted its stake in shares of Synopsys, Inc. (NASDAQ:SNPS) by 12.6% during the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 755,009 shares of the semiconductor company’s stock after buying an additional 84,524 shares during the period. Synopsys makes up approximately 0.7% of Carillon Tower Advisers Inc.’s holdings, making the stock its 19th biggest holding. Carillon Tower Advisers Inc. owned 0.50% of Synopsys worth $103,651,000 as of its most recent SEC filing.

Other hedge funds also recently made changes to their positions in the company. BlackRock Inc. grew its stake in shares of Synopsys by 4.5% during the 2nd quarter. BlackRock Inc. now owns 12,891,437 shares of the semiconductor company’s stock worth $1,658,997,000 after acquiring an additional 554,602 shares in the last quarter. JPMorgan Chase & Co. grew its stake in shares of Synopsys by 18.1% during the 2nd quarter. JPMorgan Chase & Co. now owns 6,228,559 shares of the semiconductor company’s stock worth $782,432,000 after acquiring an additional 955,527 shares in the last quarter. Invesco Ltd. grew its stake in shares of Synopsys by 33.9% during the 2nd quarter. Invesco Ltd. now owns 3,505,038 shares of the semiconductor company’s stock worth $451,061,000 after acquiring an additional 888,033 shares in the last quarter. Nuveen Asset Management LLC grew its stake in shares of Synopsys by 4,054.6% during the 2nd quarter. Nuveen Asset Management LLC now owns 1,958,501 shares of the semiconductor company’s stock worth $252,039,000 after acquiring an additional 1,911,360 shares in the last quarter. Finally, California Public Employees Retirement System grew its stake in shares of Synopsys by 9.8% during the 3rd quarter. California Public Employees Retirement System now owns 1,200,695 shares of the semiconductor company’s stock worth $164,795,000 after acquiring an additional 107,078 shares in the last quarter. Hedge funds and other institutional investors own 89.19% of the company’s stock.

In related news, General Counsel John F. Runkel, Jr. sold 10,000 shares of the business’s stock in a transaction dated Friday, August 23rd. The stock was sold at an average price of $137.47, for a total value of $1,374,700.00. Following the completion of the transaction, the general counsel now owns 16,848 shares of the company’s stock, valued at $2,316,094.56. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, VP Sudhindra Kankanwadi sold 8,011 shares of the business’s stock in a transaction dated Thursday, September 5th. The shares were sold at an average price of $144.30, for a total value of $1,155,987.30. Following the completion of the transaction, the vice president now directly owns 8,663 shares of the company’s stock, valued at approximately $1,250,070.90. The disclosure for this sale can be found here. In the last ninety days, insiders sold 22,589 shares of company stock valued at $3,158,514. 1.84% of the stock is owned by insiders.

NASDAQ:SNPS opened at $136.21 on Friday. The stock has a market capitalization of $20.38 billion, a PE ratio of 48.30, a P/E/G ratio of 3.32 and a beta of 1.20. The firm has a fifty day simple moving average of $136.69 and a 200 day simple moving average of $130.73. Synopsys, Inc. has a 1-year low of $79.14 and a 1-year high of $146.66. The company has a current ratio of 0.99, a quick ratio of 0.90 and a debt-to-equity ratio of 0.03.

Synopsys (NASDAQ:SNPS) last posted its quarterly earnings results on Wednesday, August 21st. The semiconductor company reported $0.65 EPS for the quarter, beating the Zacks’ consensus estimate of $0.62 by $0.03. The business had revenue of $853.00 million during the quarter, compared to the consensus estimate of $831.03 million. Synopsys had a return on equity of 16.56% and a net margin of 18.94%. Synopsys’s revenue for the quarter was up 9.5% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.95 earnings per share. On average, equities analysts predict that Synopsys, Inc. will post 3.15 earnings per share for the current fiscal year.

SNPS has been the subject of several research reports. ValuEngine cut shares of Synopsys from a “buy” rating to a “hold” rating in a research note on Wednesday, October 2nd. KeyCorp raised their price target on shares of Synopsys from $152.00 to $153.00 and gave the stock an “overweight” rating in a research note on Thursday, August 22nd. Credit Suisse Group reissued a “positive” rating and issued a $150.00 target price (up from $125.00) on shares of Synopsys in a research note on Thursday, August 22nd. Wells Fargo & Co reissued an “outperform” rating and issued a $160.00 target price (up from $150.00) on shares of Synopsys in a research note on Thursday, August 22nd. Finally, JPMorgan Chase & Co. raised their target price on shares of Synopsys from $138.00 to $157.00 and gave the company a “neutral” rating in a research note on Wednesday, September 11th. Four research analysts have rated the stock with a hold rating, eight have assigned a buy rating and one has assigned a strong buy rating to the company. The stock has a consensus rating of “Buy” and an average price target of $145.64.

Synopsys Profile

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits (ICs). It offers Fusion Design Platform, a digital design implementation solution; Verification Continuum Platform, which provides virtual prototyping, static and formal verification, simulation, emulation, field-programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.

Read More: Percentage Gainers

Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS).

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2019 BBNS.